A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice

被引:14
|
作者
Zhao, JH
Sun, SJ
Horiguchi, H
Arao, Y
Kanamori, N
Kikuchi, A
Oguma, E
Kayama, F
机构
[1] Jichi Med Sch, Ctr Community Med, Dept Environm Med, Minami Kawachi, Tochigi 3290498, Japan
[2] Hebei Med Univ, Second Hosp, Shijiazhuang 050000, Peoples R China
[3] Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan
[4] Hebei Med Univ, Coll Publ Hlth, Shijiazhuang 050017, Peoples R China
关键词
soy diet; isoflavones; proteinuria; kidney damage; autoimmune MRL/Mp-lpr/lpr mice;
D O I
10.1016/j.intimp.2005.04.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Isoflavones, which are phytoestrogens present in large quantities in soy and soy-derived products, have estrogenic activity, inhibit protein tyrosine kinase, and exert other effects in the human body. Thus, the recent spread of soy consumption in Western populations emphasizes the need to more fully understand the potential effects in the body, especially in abnormal immune conditions. In the present study, the influence of a soy diet on lupus disease in MRL/Mp-lpr/lpr (MRL/lpr) mice was investigated. Weanling female MRL/lpr mice (4 weeks) were fed a soy diet (20% soybean protein and 5% soybean oil). The soy diet exacerbated renal damage; findings in this mouse strain included accelerated proteinuria, elevated serum creatinine concentrations, and reduced creatinine clearance. No effects were detected, however, in C3H/HeN mice, which have the same H-2(k) genetic background as MRL/lpr mice do. A tendency toward an increase in thymus weight and proliferation of T cells in spleen and B cells in lymph nodes were found at the age of 16 weeks. These findings indicate that a soy diet, in comparison with a casein diet, significantly exacerbates the clinical course of this autoimmune disease. Further research on the mechanism of this effect of soy-rich diets is needed, and isoflavone supplementation for systemic lupus erythematosus patients should be carefully reevaluated. (c) 2005 Published by Elsevier B.V.
引用
收藏
页码:1601 / 1610
页数:10
相关论文
共 50 条
  • [22] AUTOIMMUNE OCULAR DISEASE IN MRL MP-LPR LPR MICE IS SUPPRESSED BY MONOCLONAL ANTI-CD4 ANTIBODY
    JABS, DA
    PRENDERGAST, RA
    FASEB JOURNAL, 1991, 5 (06): : A1634 - A1634
  • [23] AUTOIMMUNE OCULAR DISEASE IN MRL/MP-LPR/LPR MICE IS SUPPRESSED BY MONOCLONAL ANTI-CD4 ANTIBODY
    JABS, DA
    PRENDERGAST, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 934 - 934
  • [24] FK506 - THERAPEUTIC EFFECTS ON LUPUS DERMATOSES IN AUTOIMMUNE-PRONE MRL/MP-LPR/LPR MICE
    FURUKAWA, F
    IMAMURA, S
    TAKIGAWA, M
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (06) : 558 - 563
  • [25] STOCHASTIC-CONTROL OF ANTI-SM AUTOANTIBODIES IN MRL/MP-LPR/LPR MICE
    EISENBERG, RA
    CRAVEN, SY
    WARREN, RW
    COHEN, PL
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03): : 691 - 697
  • [26] Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice
    Jabs, DA
    Lee, B
    Burek, CL
    Saboori, AM
    Prendergast, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (02) : 377 - 383
  • [27] Lupus in interleukin-6 intact and deficient MRL/MP-lpr/lpr mice.
    Franchimont, N
    Ma, J
    Peng, OS
    Craft, J
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 550 - 550
  • [28] Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice
    Furukawa, Fukumi
    Yoshimasu, Takashi
    Yamamoto, Yuki
    Kanazawa, Nobuo
    Tachibana, Takao
    AUTOIMMUNITY REVIEWS, 2009, 8 (06) : 495 - 499
  • [29] MONOCLONAL IGM RHEUMATOID FACTORS DERIVED FROM ARTHRITIC MRL MP-LPR LPR MICE
    THEOFILOPOULOS, AN
    BALDERAS, RS
    HANG, L
    DIXON, FJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (03): : 901 - 919
  • [30] IL-12-encoding plasmid has a beneficial, effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice
    Hagiwara, E
    Okubo, T
    Aoki, I
    Ohno, S
    Tsuji, T
    Ihata, A
    Ueda, A
    Shirai, A
    Okuda, K
    Miyazaki, J
    Ishigatsubo, Y
    CYTOKINE, 2000, 12 (07) : 1035 - 1041